Home/Pipeline/Endometriosis Genetic Study

Endometriosis Genetic Study

Endometriosis

DiscoveryActive

Key Facts

Indication

Endometriosis

Phase

Discovery

Status

Active

Company

Juneau Biosciences

About Juneau Biosciences

Juneau Biosciences is a private, pre-revenue biotech company dedicated to advancing women's health through genetic research and product development. Its core focus is on identifying genetic markers for endometriosis to create diagnostic tools and potential therapeutics, leveraging a population-based gene mapping approach. The company is actively recruiting participants and physicians for its genetic studies, indicating a research-heavy, early-stage operational model. Its success hinges on validating genetic discoveries and translating them into clinically viable products.

View full company profile

Therapeutic Areas

Endometriosis Infertility

Other Endometriosis Drugs

Drug	Company	Phase	Status
Promarker™Endo	Proteomics International	Late‑stage validation	Active
EV‑Endo	Cartherics	Preclinical	Active
Endometriosis Program	Cyclana Bio	Discovery	Active
Potential Diagnostic Development	Juneau Biosciences	Research	Active
Endometriosis Discovery Program	Metri Bio	Discovery	Active
Endometriosis Test Suite	Heranova Lifesciences	Pre-clinical	Active
EndomTest	Kephera Diagnostics	Commercial (LDT)	Active
ENDO-205	EndoCyclic Therapeutics	Phase 1	Active
Undisclosed Immunotherapy	Apheon Bioscience	Preclinical	Active
FMC	FimmCyte	Pre-clinical	Active
ABC-201	Abcely	Preclinical	Active
ERβ Modulator Program	Cadenza Bio	Preclinical	Active